Finding Proper Treatment for Back Pain Sufferers {Interview}

Finding Proper Treatment for Back Pain Sufferers {Interview}
Cynthia Tait-Editor-Book Reviews-Interviews at Michigan Mama News

80% of people will feel back pain at some point in their lives and it’s the number two most common reason for visits to the doctor’s office.

While the causes of back pain may vary, vertebral compression fractures (VCFs) caused by osteoporosis pose significant burden for patients[1] and the healthcare system.[2] VCF is a break in a part of the vertebra. Vertebrae are the round, strong bones that form your spine. After one spinal fracture, the risk for having another is five times greater, so it is important to seek timely treatment – without treatment, patients are not only at risk for experiencing a diminished quality of life, but they are also at increased risk for developing serious and potentially fatal medical conditions.

Osteoporosis is a common cause of VCF,[3],[4] a debilitating and costly condition. In 2000, there were an estimated nine+ million new osteoporotic fractures that came to medical attention, of which 1.6 million were at the hip, 1.7 million at the forearm, and 1.4 million were VCF[5] – 700,000 in the US alone[6]. The incidence of VCFs is likely to increase as the nation’s population ages.[7]

Now there is a new way to identify, diagnose and treat VCF patients in an appropriate and timely manner. It’s called the VCF Care Pathway, a way for those with moderate or severe back pain to receive standardized treatment across hospitals and from healthcare providers (HCP) using the care continuum in the U.S. The National Osteoporosis Foundation believes that educating the community on appropriate patient care and working towards national standards is critical if we are going to advance care of vertebral fracture patients.

Join me in a recent interview with Dr Joshua Hirsch from Massachusetts General Hospital and Liz Thompson, CEO of the National Osteoporosis Foundation, as they discussed the topic of back injuries resulting from a number of conditions, including overall health risks and osteoporosis and explain the latest technology to provide the most up-to-date treatment.

See the entire interview here:

For more information, go to

BIO: Dr. Joshua Hirsch from Massachusetts General Hospital

Joshua Hirsch MD FACR FSIR FSNIS is director of Interventional Neuroradiology, chief of the Interventional Spine Service, vice chair of Interventional Radiology Quality & Safety and associate Departmental Quality Chair.  He has extensive experience in diagnosis, management and treatment of cerebrovascular disease, minimally invasive spine surgery and acute stroke treatment.

Dr. Hirsch has published over 450 papers, 40 chapters and edited multiple books in the peer-reviewed literature. He is a founding editor of the Journal of NeuroInterventional Surgery and is a past president of both the American Society of Spine Radiology (ASSR) and the Society of NeuroInterventional Surgery (SNIS). He has been elected to the board of the American Society of Interventional Pain Physicians (ASIPP), the Society for Injectable Osteoarticular Biomaterials and the American Society of Neuroradiology (ASNR). He is chair of a committee for academicians at the American College of Radiology. Dr. Hirsch was named a senior affiliate research fellow of the Neiman Policy Institute. He is an advisor to the RUC, chairs the health policy committee and member of the Niekro Foundation’s Medical Advisory Board.  Dr. Hirsch co-chairs the Neuro-Psychiatric working group developing episodic cost measures.Dr. Hirsch has received numerous awards including ones for transformational leadership at the ASSR, distinguished service at the ASNR and academic achievement at ASIPP.  He has been named one of America’s Top Doctors and a Best of Boston physician for multiple consecutive years. He is a member of the Marquis Who’s Who and was recently awarded the 100 designation from the MGH’s Cancer Center. He has been named an inaugural fellow of the SNIS for his many contributions to the field of NeuroInterventional Surgery.

He was recently featured in a NeuroNews profile

BIO: Elizabeth Thompson, Chief Executive Officer

National Osteoporosis Foundation

Liz Thompson serves as the chief executive officer of the National Osteoporosis Foundation, the nation’s only organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through awareness programs for the public and clinicians, education, advocacy and research. Osteoporosis is a major public health threat for an estimated 54 million Americans. One in two women and up to one in four men over age 50 will break a bone due to osteoporosis in their lifetime and approximately 75,000 Americans will die every year due to fractures. Liz is widely regarded for her 30 years of national and global leadership experience spanning for-profit and for-purpose organizations. She has a track record of engaging diverse stakeholders to set a common agenda for impact, raising money for research, and advocating for evidence-based high quality and high value care. Some career highlights:

·       In her first year at NOF, Liz recognized that major initiatives in quality were needed in order to advance bone health and formed the National Bone Health Policy Institute standing it up with a seed investment of $1.2M. It will officially launch in January 2019 with an economic report at the National Press Club.

·       Prior to joining the National Osteoporosis Foundation, Liz served as the President and CEO of C-Change and played a lead role in setting the national conversation around value-based cancer care. In that role, she worked passionately and tirelessly, dedicated to building a strong membership organization that harnessed the power of a movement to create research agendas, drive public policy, open access to life saving medicines, and empower people to live healthier, stronger lives.

·       As president of Susan G. Komen for the Cure, Liz transformed the culture of philanthropy on the base of the $2.9B portfolio resulting in strategic grant making in science and research, expanded community health grant making in at-risk US communities and 50 countries around the world. A world brand leader committed to world-wide impact, she engaged with more than 200 corporate and strategic alliances to jump start Pink Ribbon/Red Ribbon, an effort focused on providing diagnostic and treatment services for women who were living beyond HIV/AIDS and succumbing to cervical and breast cancer.

·       In her early career, she worked in medical and consumer healthcare publishing and through that work and her advocacy work, has had the privilege to learn from dedicated physician scientists and their patients who are making advances and innovation possible.

Protected by Copyscape

Interview is courtesy:  Medtronic

[1] Boonen S, et al. J Bone Miner Res. 2011;26(7):1627-1637.

[1] Chen AT, et al. J Bone Joint Surg Am. 2013 Oct 2;95(19):1729-1736.

[1] Evans AJ, et al. Radiology. 2003;226(2):366–372.

[1] Ross PD. Am J Med. 1997;103(2A):30S–43S.

[1] IOF.

[1] Chou S, et al.

[1] Burg R, et al. J Bone Miner Res. 2007;22:465–75.

[1] Boonen S, et al. J Bone Miner Res. 2011;26(7):1627-1637.

[2] Chen AT, et al. J Bone Joint Surg Am. 2013 Oct 2;95(19):1729-1736.

[3] Evans AJ, et al. Radiology. 2003;226(2):366–372.

[4] Ross PD. Am J Med. 1997;103(2A):30S–43S.

[5] IOF.

[6] Chou S, et al.

[7] Burg R, et al. J Bone Miner Res. 2007;22:465–75.


Cynthia Tait-Editor-Book Reviews-Interviews

Cynthia Tait

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: